The Non-Clinical Safety Assessment Lead will oversee non-clinical activities and safety assessments for Organon Research and Development (R&D) programs ranging from discovery through late-stage development. This is a scientific leadership position that includes management responsibilities of the non-clinical development scientists, who directly contribute to implementation and execution of Organon’s pipeline assets and portfolio of established brands (general medicines). This position will report to the Vice President, Translational Medicine and Early Development (TMED). As part of the Non-Clinical Development (NCD) team, the Non-Clinical Safety Assessment Lead will be responsible for ensuring the fulfillment of regulatory requirements and commitments as well as execution of strategy across the Organon portfolio, including pipeline assets, life-cycle management of approved products, business development activities, and contributions to risk assessments and information requests from health authorities for the general medicines portfolio. The NCD team is comprised of non-clinical drug development scientists representing the disciplines of toxicology, DMPK, and pharmacology, within Translational Medicine and Early Development (TMED). The Non-Clinical Safety Assessment Lead will work closely with the Translational Sciences Lead to ensure that R&D programs are adequately supported across non-clinical disciplines, including technical expertise and development strategy. Additionally, cross-functional interactions with early clinical development, late-clinical development, regulatory affairs, safety and pharmacovigilance, Chemistry, Manufacturing and Controls (CMC), medical affairs and business development are critical to the success of the role.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Education Level
Ph.D. or professional degree
Number of Employees
5,001-10,000 employees